{
  "case_id": "Case_5",
  "model_id": "anthropic/claude-3-opus-20240229",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Parkinson's disease\",\n        \"confidence\": 0.7,\n        \"icd_code\": \"G20\",\n        \"reasoning\": \"Progressive neurological symptoms of tremor, bradykinesia, rigidity, and basal ganglia abnormalities on MRI are consistent with Parkinson's disease.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Manganese toxicity\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"T57.2X1A\",\n            \"reasoning\": \"Exposure to manganese through water in Bangladesh could cause Parkinson-like symptoms. Temporal relationship fits.\"\n        },\n        {\n            \"name\": \"Progressive supranuclear palsy\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"G23.1\",\n            \"reasoning\": \"Another neurodegenerative disorder causing Parkinson-like symptoms, but typically with more rapid progression and supranuclear gaze palsy.\"\n        },\n        {\n            \"name\": \"Multiple system atrophy\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"G90.3\",\n            \"reasoning\": \"Neurodegenerative disorder that can present with Parkinsonism, but usually has additional autonomic features and cerebellar signs.\"\n        }\n    ],\n    \"key_findings\": [\n        \"3-month progressive tremor, bradykinesia, rigidity\",\n        \"Subtle basal ganglia signal abnormalities on MRI\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Blood manganese level\",\n            \"purpose\": \"Rule in/out manganese toxicity\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"DaTscan (dopamine transporter imaging)\",\n            \"purpose\": \"Assess integrity of dopaminergic system, support Parkinson's diagnosis\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Check blood manganese level\",\n            \"Start symptomatic treatment for Parkinsonism\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Carbidopa-Levodopa\",\n                \"dose\": \"25-100 mg PO TID\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite\",\n                \"rationale\": \"Mainstay treatment for Parkinson's disease, replaces dopamine\"\n            }\n        ],\n        \"monitoring\": [\n            \"Neurological exam\",\n            \"Every 3 months\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Neurology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Confirm diagnosis, guide management\"\n            },\n            {\n                \"specialty\": \"Occupational Medicine\",\n                \"urgency\": \"routine\",\n                \"reason\": \"Assess occupational exposures, guide testing\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapid progression of symptoms\",\n        \"Development of new neurological signs (e.g., gaze palsy, autonomic dysfunction)\"\n    ],\n    \"patient_education\": [\n        \"Discuss potential causes (idiopathic vs. secondary)\",\n        \"Set expectations for symptom management, not cure\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"3 months\",\n        \"conditions\": \"Worsening symptoms, intolerable side effects from medications\"\n    },\n    \"confidence_in_assessment\": 0.6,\n    \"uncertainties\": [\n        \"Etiology of Parkinsonism (idiopathic vs. manganese toxicity)\",\n        \"Optimal medication regimen\"\n    ]\n}",
  "latency": 32.22464728355408,
  "timestamp": "2025-08-10T01:16:30.290303",
  "cached_at": "2025-08-10T01:16:30.290310"
}